CH

Chao Han

SVP Early Development at Tavotek Biotherapeutics

Chao Han is currently serving as the Senior Vice President of Early Development at Tavotek Biotherapeutics. Prior to this role, Chao worked as a Scientific Director at Janssen, Pharmaceutical Companies of Johnson and Johnson, an Associate Director at Centocor, and a Manager at GlaxoSmithKline. Chao's educational background includes a Ph.D. in Pharmacology & Therapeutics from the University of Manitoba, an MS in Analytical Chemistry from Nankai University, and a BS in Chemistry from Nankai University. Additionally, Chao conducted postgraduate research at the University of California.

Links

Timeline

  • SVP Early Development

    January, 2022 - present